These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 11219145

  • 1. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
    Diercks GF, Overdiek JW, van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 2001 Feb 03; 145(5):204-8. PubMed ID: 11219145
    [Abstract] [Full Text] [Related]

  • 2. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 03; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 3. [Anti-aldosterone therapy in severe heart failure].
    van Guldener C, Donker AJ.
    Ned Tijdschr Geneeskd; 1999 Aug 21; 143(34):1724-6. PubMed ID: 10494316
    [Abstract] [Full Text] [Related]

  • 4. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005 Aug 21; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 5. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D, Frey FJ, Ferrari P.
    Praxis (Bern 1994); 2000 Dec 07; 89(49):2073-6. PubMed ID: 11190849
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 07; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aldosterone antagonists in congestive heart failure.
    Soberman J, Chafin CC, Weber KT.
    Curr Opin Investig Drugs; 2002 Jul 07; 3(7):1024-8. PubMed ID: 12186262
    [Abstract] [Full Text] [Related]

  • 9. Aldosterone and spironolactone in heart failure.
    Weber KT.
    N Engl J Med; 1999 Sep 02; 341(10):753-5. PubMed ID: 10471464
    [No Abstract] [Full Text] [Related]

  • 10. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
    Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA.
    N Engl J Med; 2004 Aug 05; 351(6):543-51. PubMed ID: 15295047
    [Abstract] [Full Text] [Related]

  • 11. An approach to heart failure and diabetes mellitus.
    Fonarow GC.
    Am J Cardiol; 2005 Aug 22; 96(4A):47E-52E. PubMed ID: 16098844
    [Abstract] [Full Text] [Related]

  • 12. [Inhibition of renin-angiotensin-aldosterone system: what evidence?].
    Mota T.
    Rev Port Cardiol; 2001 Mar 22; 20 Suppl 3():13-5. PubMed ID: 11409069
    [Abstract] [Full Text] [Related]

  • 13. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS, Cruz LS, Domingues GS, Souza CA.
    Expert Opin Drug Saf; 2005 Jul 22; 4(4):677-88. PubMed ID: 16011447
    [Abstract] [Full Text] [Related]

  • 14. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA.
    Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046
    [Abstract] [Full Text] [Related]

  • 15. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
    Shah NC, Pringle S, Struthers A.
    J Renin Angiotensin Aldosterone Syst; 2006 Mar 26; 7(1):20-30. PubMed ID: 17083070
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
    Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JG.
    Eur Heart J; 2005 Dec 26; 26(24):2706-13. PubMed ID: 16183692
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Blocking of aldosterone receptors reduces the risk of events in patients with severe cardiac failure].
    Opasich C.
    Ital Heart J Suppl; 2000 Mar 26; 1(3):425-6. PubMed ID: 10815276
    [No Abstract] [Full Text] [Related]

  • 20. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.
    Circulation; 2004 Nov 16; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.